Advances in colorectal cancer screening

被引：7

作者：

Vu H.T. ^{[1
]}

Burke C.A. ^{[1
]}

机构：

[1] Digestive Disease Institute, Department of Gastroenterology and Hepatology, Cleveland Clinic Foundation, Cleveland, OH 44195, 9500 Euclid Avenue

来源：

Current Gastroenterology Reports | 2009年 / 11卷 / 5期

关键词：

Fecal Occult Blood Testing; Colorectal Cancer Screening; Fecal Immunochemical Test; Advanced Adenoma; Advanced Neoplasia;

D O I：

10.1007/s11894-009-0061-z

中图分类号：

学科分类号：

摘要：

Colorectal cancer (CRC) remains the third most commonly diagnosed cancer and second leading cause of cancer death in the United States. Declines in CRC incidence and mortality over the past 20 years were attributed to CRC screening. Yet, only slightly more than half of the eligible at-risk population acknowledge being screened. To effectively meet the demands of screening in an enlarging, ethnically diverse, and aging population, a variety of modalities are needed. This article provides a focused assessment of effectiveness, limitations, and alternative available screening methods. New modalities endorsed in the updated guidelines (eg, fecal immunochemical tests, fecal DNA, and CT colonography) are reviewed. In addition, advances and updates in existing tests (eg, guaiac-based fecal occult blood tests and colonoscopy) are evaluated. © Current Medicine Group, LLC 2009.

引用

页码：406 / 412

页数：6

共 37 条

[1]

Jemal A., Siegel R., Ward E., Et al., Cancer statistics, 2008, CA Cancer J Clin, 58, pp. 71-96, (2008)

[2]

Meissner H.I., Breen N., Klabunde C.N., Et al., Patterns of colorectal cancer screening and uptake among men and women in the United States, Ca Epidemiol Biomarkers Prev, 15, pp. 389-394, (2006)

[3]

Smith R.A., Cokkinides V., Brawley O.W., Cancer screening in the United States, 2009: A review of current American Cancer Society guidelines and issues in cancer screening, CA Cancer J Clin, 59, pp. 27-41, (2009)

[4]

Horner M.J., Ries L.A.G., Krapcho M., Et al., SEER Cancer Statistics Review, 1975-2006

[5]

Rundle A.G., Lebwohl B., Vogel R., Et al., Colonoscopic screening in average-risk individuals ages 40 to 49 vs 50 to 59 years, Gastroenterology, 134, pp. 1311-1315, (2008)

[6]

Imperiale T.F., Wagner D.R., Lin C.Y., Et al., Results of screening colonoscopy among persons 40 to 49 years of age, N Engl J Med, 346, pp. 1781-1785, (2002)

[7]

Stevens T., Burke C.A., Colonoscopy screening in the elderly: When to stop?, Am J Gastroenterol, 98, pp. 1881-1885, (2003)

[8]

Kahi C.J., Azzouz F., Juliar B.E., Et al., Survival of elderly persons undergoing colonoscopy: Implications for colorectal cancer screening and surveillance, Gastrointest Endosc, 66, pp. 544-550, (2007)

[9]

Duncan J.E., Sweeney W.B., Trudel J.L., Et al., Colonoscopy in the elderly: Low risk, low yield in asymptomatic patients, Dis Colon Rectum, 49, pp. 646-651, (2006)

[10]

Ko C.W., Sonnenberg A., Comparing risks and benefits of colorectal cancer screening in elderly patients, Gastroenterology, 129, pp. 1163-1170, (2005)

← 1 2 3 4 →